Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D-Alanyl-D-alanine dipeptide terminus is a structural motif on the pentapeptide stem of bacterial peptidoglycan, found at the ends of nascent peptidoglycan precursors. This motif is generated in the cytoplasm by D-Ala-D-Ala ligase and is essential for the elongation and cross-linking of peptidoglycan, which gives bacteria their mechanical strength and protects against osmotic lysis. The D-Ala-D-Ala motif is the direct binding site of glycopeptide antibiotics such as vancomycin, whose mechanism of action involves prevention of cell wall synthesis by blocking transpeptidase-mediated crosslinking. The motif is also the molecular mimic for β-lactam antibiotics, which inhibit the crosslinking enzymes (transpeptidases). Replacement of the terminal D-Ala with D-Lactate (D-Ala-D-Lac) confers intrinsic or acquired resistance to vancomycin in certain bacteria. The D-Ala-D-Ala motif is not a protein, enzyme, or receptor, but a carbohydrate-linked dipeptide recognized as a key drug target in infectious disease therapy and antibiotic resistance research.
Vancomycin binds directly to D-Ala-D-Ala termini, blocking transpeptidation and cell wall synthesis, causing bacterial cell death\nBeta-lactam antibiotics mimic D-Ala-D-Ala and irreversibly inhibit transpeptidases responsible for crosslinking peptidoglycan\nD-cycloserine inhibits D-Ala-D-Ala ligase, depleting precursor availability for cell wall biosynthesis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-Alanyl-D-alanine dipeptide terminus of bacterial peptidoglycan (D-Ala-D-Ala).